SHR-A2009 ; Aumolertinib
SHR-A2009-302
Phase 3 small_molecule active
Quick answer
SHR-A2009 ; Aumolertinib for Non-small Cell Lung Cancer is a Phase 3 program (small_molecule) at Suzhou Ribo Life Science Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Suzhou Ribo Life Science Co.
- Indication
- Non-small Cell Lung Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active